| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
|
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,830,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,313,530 |
|
|
|
Indirect Value
|
$155,315,778 |
|
|
| Total
Shares |
10,573,900 |
|
|
| Total
Value |
$156,629,308 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRON |
Kronos Bio, Inc. |
President & CEOOfficer |
• • • |
2020-10-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,121,161 |
|
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEOOfficer |
• • – |
2020-10-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,121,159 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-02-13 |
4 |
A |
$85.61 |
$21,232 |
D/D |
248 |
119,550 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2016-02-15 |
4 |
A |
$76.02 |
$18,854 |
D/D |
248 |
165,416 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
250 |
47,286 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
250 |
47,036 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
22,287 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
12,793 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-05-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
450 |
92,322 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2003-10-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
500 |
47,536 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2012-06-29 |
4 |
A |
$29.02 |
$21,271 |
D/D |
733 |
1,076,219 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-02-14 |
4 |
A |
$21.94 |
$21,243 |
D/D |
968 |
69,092 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-10-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,100 |
88,722 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2006-10-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,250 |
87,472 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-10-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,300 |
92,772 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-11-12 |
4 |
S |
$47.16 |
$94,319 |
I/I |
(2,000) |
12,394 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-10-25 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,500 |
89,822 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2012-11-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,620 |
1,073,599 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2016-08-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,800 |
2,316,849 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2003-12-19 |
4 |
OE |
$6.53 |
$19,594 |
D/D |
3,000 |
185,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-07-07 |
4 |
AS |
$119.39 |
$446,400 |
D/D |
(3,739) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-11-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
2,158,681 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2014-08-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
2,154,681 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2008-11-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
44,394 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-11-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
2,149,681 |
0 |
- |
|
192 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
